Breed's Hill Capital’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$528K Buy
4,914
+1
+0% +$101 0.25% 63
2025
Q1
$496K Hold
4,913
0.27% 61
2024
Q4
$439K Buy
4,913
+1,473
+43% +$130K 0.23% 72
2024
Q3
$288K Hold
3,440
0.24% 73
2024
Q2
$265K Hold
3,440
0.23% 72
2024
Q1
$236K Buy
+3,440
New +$221K 0.22% 78

Other funds holding BSX

Breed's Hill Capital's BSX Position: Q2 2025 in Review

Breed's Hill Capital increased its Boston Scientific (BSX) stake by 0.02% in Q2 2025, buying an estimated $101 and bringing the position to 4,914 shares worth $528K. The position accounts for 0.25% of the portfolio, ranked #63.

Breed's Hill Capital first reported a position in BSX in Q1 2024 and has held it in 6 quarters since. 1,693 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

  • Breed's Hill Capital held 4,914 shares of Boston Scientific worth $528K as of Q2 2025.
  • Breed's Hill Capital bought 1 Boston Scientific share in Q2 2025, an estimated $101.
  • Boston Scientific made up 0.25% of Breed's Hill Capital's portfolio in Q2 2025, its #63 holding.
  • Breed's Hill Capital first reported a position in Boston Scientific in Q1 2024 and has held it in 6 quarters since.
  • 1,693 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Breed's Hill Capital's 13F filing for Q2 2025, filed 8 Aug 2025.